Legal Representation
Attorney
Kathleen Gallagher-Duff
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 5, 2018 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 5, 2018 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jul 5, 2018 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Dec 12, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 12, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 12, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 4, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 7, 2017 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 6, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 1, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Clinical trials for use of an antifungal pharmaceutical preparation for pediatric patients
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the word TOPSPIN in large font and the words TRIAL OF ISAVUCONAZONIUM SULFATE IN PEDIATRIC PATIENTS in smaller font below it, all over a spinning top design.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"TRIAL OF ISAVUCONAZONIUM SULFATE IN PEDIATRIC PATIENTS"